We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amphenol Corporation (APH - Free Report) designs and manufactures connectors and interconnecting systems that are used to transmit electrical and optical signals for a wide range of sophisticated electronic applications.
In the last four quarters, Amphenol has reported a positive average earnings surprise of 9.41%, beating estimates on all occasions.
Zacks Rank: Currently, Amphenol has a Zacks Rank #4 (Sell) but that could change following its first-quarter 2018 earnings report which has just released.
Check back later for our full write up on this Amphenol earnings report later!
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Image: Bigstock
Amphenol (APH) Beats Q1 Earnings, Revenues Surge Y/Y
Amphenol Corporation (APH - Free Report) designs and manufactures connectors and interconnecting systems that are used to transmit electrical and optical signals for a wide range of sophisticated electronic applications.
In the last four quarters, Amphenol has reported a positive average earnings surprise of 9.41%, beating estimates on all occasions.
Zacks Rank: Currently, Amphenol has a Zacks Rank #4 (Sell) but that could change following its first-quarter 2018 earnings report which has just released.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
We have highlighted some of the key details from the just-released announcement below:
Earnings: Amphenol’s adjusted earnings came in at 83 cents per share, which beat the Zacks Consensus Estimate by three cents.
Revenues: Revenues of $1.87 billion beat the Zacks Consensus Estimate of $1.80 billion and increased 19.7% on a year-over-year basis.
Key Stats: Adjusted operating income increased 20% year over year to $376.9 million.
Stock Price: Shares price did not show any movement in the pre-market trading session.
Amphenol Corporation Price
Amphenol Corporation Price | Amphenol Corporation Quote
Check back later for our full write up on this Amphenol earnings report later!
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>